Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
Clinical trial NCT05220358 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05220358
- Sponsor
- Orlando Immunology Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2026-02-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.